ds-dp

High Potent Compound & Controlled Substances

J-STAR Research’s State-of-the-Art facilities are fully equipped & licensed to meet common, critical needs, including:

Controlled Substances (DEA Schedule II-V)

J-STAR’s South Plainfield facility is registered with the DEA as a research facility for schedules II-V. Our chemists are trained

Drug Product

Balancing Speed with Depth in Formulation Development

We specialize in early-phase drug product formulation development. Our philosophy is to develop “fit-for-purpose” formulations in early phases to minimize complexity and accelerate timelines.

  • Design formulations, e.g., API-in-bottle, API-in-capsule, capsule, tablet, solution, semisolid,

Process Chemistry Research & Development

Essential Groundwork for any Compound

Client medicinal chemistry processes commonly face multiple risks and challenges, including:

  • Lengthy syntheses
  • Multiple column chromatography steps
  • Low-yielding reactions
  • Scaling issues when moving from milligrams to hundreds of grams
  • Hazardous reagents
  • Non-environmentally friendly chemistries
  • Reaction

Analytical R&D and Quality Control


Analytical Services

J-STAR Research provides analytical development and quality control (QC) expertise at all stages of Drug Substance (DS) and Drug Product (DP) development. Our team of expert scientists, equipped with tailored workflows and advanced instrumentation, delivers actionable insights that

Crystallization R&D

Crystallization R&D

Headed by science-centric subject matter experts, the Crystallization R&D is recognized as an industry preferred partner in solid form screening and selection, crystallization process development, pre-formulation, particle engineering and Drug Substance (DS) Drug Product (DP) co-processing. Applying over

Scroll to Top